ClinicalTrials.govpublic full text
Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
nasopharyngeal carcinoma, lymphomas, any ebv+ solid tumour, nasopharyngeal carcinoma, antiangiogenesis, hdaci, mtor, phase ib, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907871
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.